Cohort study reveals oral adverse drug events in patients with psoriasis, indicating risks of immunosuppressive therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lanehart et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: